Search Results
Jun 08, 2026, 07:00 ET Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
immunotherapy company and a pioneer in computational target discovery powered by AI/ML, today announced that management will participate in Jones Trading's Mapping the Path from Target to Patient: Fireside Chat Series with Leaders in AI/ ML-based Drug Development on Monday, June 15, 2026, from 10:30-11:00 AM ET.
More news about: Compugen Ltd.
Jun 07, 2026, 16:45 ET AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
https://doi.org/10.1001/jama.2026.3277Shapiro MD. Circulation. 2022;146(15):1120-1122. Rao SV, O'Donoghue ML, Ruel M, et al. Circulation. 2025;151(13):e771-e862.Data on File. Amgen, 2025.Singh V, Sun J, Cheng S, Kwan AC, Velazquez A. Obesity
More news about: Amgen
Jun 07, 2026, 11:00 ET Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
formulation of Foundayo at dosages equivalent to Foundayo tablets.Endnotes and ReferencesKapoor E, Collazo-Clavell ML, Faubion SS. Weight gain in women at midlife: a concise review. J Clin Endocrinol Metab. 2017;102(10):3732-3741.North American Menopause Society.
More news about: Eli Lilly and Company
Jun 05, 2026, 10:23 ET Update zu innovativem Arzneimittel | Kexing Biopharm nimmt ersten Studienteilnehmer in die in China durchgeführte klinische Phase-I-Studie mit dem innovativen ophthalmologischen Arzneimittel GB10 auf
eigenständig entwickelt wurde. Sie enthält einen bispezifischen Antikörper, der gegen VEGF und Ang-2 gerichtet ist. Mit einer hohen Konzentration von 140 mg/ml ermöglicht GB10 Injection ein geringeres Injektionsvolumen oder eine höhere Dosierung und verlängert dadurch das Verabreichungsintervall. Es wird erwartet,
More news about: Kexing Biopharm
Jun 05, 2026, 09:58 ET Bybit se torna a primeira grande corretora de criptomoedas a integrar a stablecoin USDPT da Western Union, conectando dois mundos financeiros por meio de uma única stablecoin
ora-de-criptomoedas-a-integrar-a-stablecoin-usdpt-da-western-union-conectando-dois-mundos-financeiros-por-meio-de-uma-unica-stablecoin-302792735.htmlFONTE Bybit
More news about: Bybit
Jun 05, 2026, 06:16 ET Actualización sobre fármacos innovadores | Kexing Biopharm inscribe al primer sujeto en el ensayo clínico de fase I en China del fármaco oftálmico innovador GB10
biespecífico que se dirige tanto al factor de crecimiento endotelial vascular (FCEV) como a la angiopoyetina-2 (Ang-2). Con una alta concentración de 140 mg/ml, el GB10 inyectable permite un menor volumen de inyección o una dosis más alta, lo que prolonga el intervalo entre dosis. Se espera que permita un régimen
More news about: Kexing Biopharm
Jun 05, 2026, 06:13 ET Atualização sobre medicamentos inovadores | Kexing Biopharm recruta o primeiro participante para o ensaio clínico de Fase I do medicamento oftalmológico inovador GB10, realizado na China
independente pela Shenzhen Kexing. Ele contém um anticorpo biespecífico que tem como alvo ambas as proteínas VEGF e Ang-2. Com uma alta concentração de 140 mg/mL, a injeção de GB10 permite um volume de injeção menor ou uma dosagem mais elevada, aumentando assim o intervalo entre as doses. O objetivo é alcançar
More news about: Kexing Biopharm
Jun 05, 2026, 06:00 ET Nieuws over innovatieve geneesmiddelen | Kexing Biopharm neemt eerste proefpersoon op in de in China uitgevoerde fase I-klinische studie naar het innovatieve oogheelkundige geneesmiddel GB10
Kexing zelfstandig is ontwikkeld. Het bevat een bispecifiek antilichaam dat zich zowel op VEGF als op Ang-2 richt. Dankzij de hoge concentratie van 140 mg/ml maakt GB10 Injectie een kleiner injectievolume of een hogere dosering mogelijk, waardoor het doseringsinterval kan worden verlengd. Naar verwachting
More news about: Kexing Biopharm
Jun 05, 2026, 05:25 ET Mise à jour de médicament novateur | Kexing Biopharm recrute le premier sujet de l'essai clinique de phase I en Chine du médicament innovant ophtalmique GB10
indépendamment par Shenzhen Kexing. Il s'agit d'un anticorps bispécifique ciblant à la fois le VEGF et l'Ang-2. Avec une concentration élevée de 140 mg/ml, GB10 Injection permet de réduire le volume d'injection ou d'augmenter le dosage, ce qui permet d'allonger l'intervalle entre les prises. Il devrait
More news about: Kexing Biopharm
Jun 04, 2026, 17:33 ET BW Lawsuit Alleges Company Allegedly Violated Disclosure Regulations - Babcock & Wilcox Enterprises Investors Face Losses Following Company Allegedly Violated Disclosure Regulations: SueWallSt
-regulations---babcock--wilcox-enterprises-investors-face-losses-following-company-allegedly-violated-disclosure-regulations-suewallst-302791976.htmlSOURCE SueWallSt.com
More news about: SueWallSt.com
Jun 04, 2026, 16:39 ET Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
pre-filled syringes (PFS). Both the vial and PFS presentations are approved in both strengths available for Lucentis®, 0.3 mg (0.05 mL of 6 mg/mL), and 0.5 mg (0.05 mL of 10 mg/mL). Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds and inhibits vascular endothelial
More news about: Lupin Pharmaceutical, Inc.
Jun 04, 2026, 12:00 ET Ny undersøgelse fra Apica: Agentbaseret AI forventes at udløse en 9,5-dobling af telemetridata, hvilket vil efterlade de fleste virksomheder sårbare
på denne stigning54 % af virksomhederne har allerede oplevet en tredobling af mængden af telemetridata i løbet af de seneste 12 måneder; AI/ML tegner sig nu for ca. 43 % af den samlede vækst i telemetridata, og denne andel er stigendeVirksomhederne oplyser, at de i gennemsnit bruger
More news about: Apica
Jun 04, 2026, 10:13 ET IDBS i3 2026 forum in Boston showcases real-world customer outcomes in data-driven BioPharma
IDBS, a Danaher company, helps biopharma organizations unlock the potential of AI/ML to improve the lives of patients. As a trusted long-term partner to 75% of the top 20 global biopharma companies1, IDBS delivers powerful
More news about: IDBS
Jun 04, 2026, 09:00 ET ESPOLÒN® TEQUILA UNLEASHES EXTRA AÑEJO: SHOWCASING A NEW DIMENSION OF AGING, THE ESPOLÒN WAY
espolontequila.com (for delivery in select markets) with an MSRP of $69.99 for a 750mL bottle.Espolòn Tequila encourages adults 21 and up to savor Extra Añejo (40% Alc./Vol.) either neat, on the rocks or in the signature Espolòn
More news about: Espolòn Tequila
Jun 04, 2026, 08:30 ET NATURE'S MIRACLE HOLDING INC. ANNOUNCES STRATEGIC PARTNERSHIP WITH FARADAY FUTURE ("FFAI")TO SUPPORT NORTH AMERICAN ROBOTICS DEPLOYMENT ALONG WITH DELIVERY OF THE INITIAL AEGIS PRO And NAVI ROBOTS
hip-with-faraday-future-ffaito-support-north-american-robotics-deployment-along-with-delivery-of-the-initial-aegis-pro-and-navi-robots-302791156.htmlSOURCE Nature's Miracle Holding Inc.
More news about: Nature's Miracle Holding Inc.
Jun 04, 2026, 06:53 ET Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10
formulation independently developed by Shenzhen Kexing. It features a bispecific antibody targeting both VEGF and Ang-2. With a high concentration of 140 mg/mL, GB10 Injection allows for a smaller injection volume or higher dosage, thereby extending the dosing interval. It is expected to achieve a "once per
More news about: Kexing Biopharm
Jun 04, 2026, 04:22 ET Uusi Apica-tutkimus: Agenttinen tekoäly on valmis laukaisemaan 9,5-kertaisen telemetriatietojen räjähdysmäisen kasvun, joka jättää suurimman osan yrityksistä haavoittuvaisiksi
varautuneita tähän räjähdysmäiseen kasvuun54 % yrityksistä on jo kolminkertaistanut telemetriatietojen määrän viimeisen 12 kuukauden aikana; AI/ML vastaa nyt n. 43 % kaikesta telemetrian kasvusta, ja osuus on kasvussaYritykset ilmoittavat käyttävänsä vuosittain keskimäärin 3,17 miljoonaa
More news about: Apica
Jun 03, 2026, 13:00 ET INTRODUCING NIGHT SAGE BLENDED CANADIAN WHISKY AGED 25 YEARS FROM THE ORPHAN BARREL COLLECTION
TheBar.com and ReserveBar.com for a suggested retail price of $225 per 750mL bottle. Experience the full interactive Multichannel News Release here:
More news about: DIAGEO
Jun 03, 2026, 11:51 ET What If the Best Way to Protect Data Was to Delete It First?
models that are just as powerful, arguably more so. As EVP of AI & Innovation Jeremy Samuelson put it, the goal is to "protect the data that powers ML models without limiting their value and without willingly exposing it by using aging frameworks.""The time has come where we need to stop giving
More news about: Equity Insider
Jun 03, 2026, 10:53 ET 후보물질 식별부터 리드 최적화까지: 초기 신약 개발의 과학적 연속성 구축
기여한다.의약화학 관점에서 드와이트 박사는 설계-합성-시험-분석 사이클에는 명확한 가설과 의약화학, AIDD/CADD, 생물학, DMPK, 프로젝트팀 간 긴밀한 협업이 필요하다고 강조했다. 구조 기반 설계, SAR 분석, FEP, MD 시뮬레이션, ADMET 예측, AI/ML 지원 모델링은 모두 집중적인 화합물 우선순위 설정에 기여할 수 있다.이번 논의는 통합이 단순히 기능들을 한곳에 모으는 것이 아니라, 진행/중단 기준을 포함해 올바른 데이터, 전문성, 의사결정 지점을 연결하는 것이라는 점을 재확인했다. 비바 바이오텍은 통합된
More news about: Viva Biotech
Jun 03, 2026, 10:00 ET RUSSELL'S RESERVE® HONORS EDDIE RUSSELL'S 45-YEAR LEGACY WITH A CINEMATIC TRIBUTE AND THE SPRING 2026 RETURN OF THE 13 YEAR OLD
Russell's Reserve 13 Year Old will be available in limited quantities online, at the distillery Visitor's Center and at select retailers for $200 SRP per 750 ML bottle. For news of how to purchase, sign up for the Russell's Reserve newsletter at
More news about: Russell’s Reserve
Jun 03, 2026, 09:02 ET BuzzBallz Goes Global For The Big Tournament With Its "Buzz Around the World" Bar Cart
(Argentina)GOOOAAAAAAL Melon (all countries)Soccer Lime Rita (soccer jersey inspired)Whether you're grabbing the classic 200ml cocktails (starting at $3.99) or going big with the shareable 3-liter Boulder ($29.99), SoccerBallz keeps the flavor in play from the first whistle to
More news about: BuzzBallz
Jun 03, 2026, 09:00 ET Vectra AI Delivers Unified Network Observability Across All Major Cloud Platforms to Stop Hybrid Threats Faster
Vectra AI helps organizations reduce exposure, accelerate detection and response, and automate security operations with AI. With over a decade of AI and ML innovation and 39 patents, Vectra AI empowers security teams to stay ahead of emerging AI powered attacks, increase operational efficiency, and prove
More news about: Vectra AI
Jun 03, 2026, 08:00 ET Zifo to Present Biobank Data Breakthrough at the Festival of Genomics Boston
Provenance: The integration of strict auditability, role-based access, and FAIR-aligned data pathways designed to feed directly into downstream AI/ML models.Connect with Zifo at Stand 44"Advanced therapeutics require a data foundation that moves at the speed of scientific
More news about: Zifo
Jun 03, 2026, 08:00 ET New Apica Research: Agentic AI Poised to Trigger 9.5x Telemetry Data Explosion, Leaving Most Enterprises Exposed
two-thirds are only "somewhat prepared" or worse for that surge54% of enterprises already saw telemetry data volume triple in the past 12 months; AI/ML now accounts for ~43% of all telemetry growth and that share is risingEnterprises report spending an average of $3.17M annually on observability
More news about: Apica